Here’s a comprehensive DCF valuation and investment analysis for Avalon Technologies (NSE: AVALON) based on the latest available financials.
Key Data Used
Financials (FY25 Actuals):
- Full year FY25 revenue was ₹1,098 Cr (up 26.6% YoY) and net profit was ₹63.44 Cr (up 126.7% YoY)
- Q3 FY26 revenue was ₹417.54 Cr and net profit ₹32.60 Cr
- Current share price: ~₹990 | P/E: ~69x | Market Cap: ~₹6,607 Cr
Growth Guidance & Analyst Estimates:
- Analysts forecast revenue growth of ~41.9% and profit growth of ~63.4% for FY26
- Management has guided for 23–25% revenue growth in FY26, with an objective to double FY24 revenues by FY27
- Prabhudas Lilladher estimates FY25–27 revenue/EBITDA/PAT CAGR of 27.5%/37.7%/45.9% with EBITDA margin expansion of ~170bps
DCF Valuation Model
Assumptions:
| Parameter | Value | Rationale |
|---|---|---|
| Base Revenue (FY25) | ₹1,098 Cr | Actual |
| Base PAT (FY25) | ₹63.4 Cr | Actual |
| Revenue CAGR (FY26–28) | 30% | Mgmt guidance + analyst consensus |
| Revenue CAGR (FY29–30) | 20% | Normalization phase |
| Terminal Growth Rate | 8% | India EMS sector long-run growth |
| Net Margin (stabilized) | 7–8% | Expanding from current ~6% |
| Discount Rate (WACC) | 14% | Indian mid-cap, beta ~1.2 |
| Shares Outstanding | ~66.8 Cr | Current |
Projected Free Cash Flows (₹ Cr):
| Year | Revenue | PAT (~7%) | FCF (70% of PAT) |
|---|---|---|---|
| FY26E | 1,427 | 100 | 70 |
| FY27E | 1,855 | 148 | 104 |
| FY28E | 2,412 | 193 | 135 |
| FY29E | 2,894 | 231 | 162 |
| FY30E | 3,473 | 277 | 194 |
Terminal Value (FY30):
- Terminal FCF: ₹194 Cr
- Terminal Value = 194 × (1.08) / (0.14 – 0.08) = ₹3,492 Cr
- PV of Terminal Value (discounted 5 years @ 14%) = ₹1,814 Cr
Sum of PV of FCFs:
| Year | FCF | PV Factor @ 14% | PV |
|---|---|---|---|
| FY26 | 70 | 0.877 | 61 |
| FY27 | 104 | 0.769 | 80 |
| FY28 | 135 | 0.675 | 91 |
| FY29 | 162 | 0.592 | 96 |
| FY30 | 194 | 0.519 | 101 |
| Terminal | — | — | 1,814 |
| Total Enterprise Value | ₹2,243 Cr |
⚠️ Note: This DCF yields a conservative intrinsic enterprise value. Adding net cash (~₹50 Cr) and dividing by 66.8 Cr shares gives an intrinsic value of ~₹345–380/share on a strict FCF basis. This reflects the reality that Avalon currently converts a low fraction of earnings to free cash flow due to high capex and working capital needs.
Relative / Earnings-Based Valuation (More Market-Relevant)
Given Avalon’s high-growth EMS profile, the market prices it on forward earnings multiples rather than pure DCF:
| Scenario | FY27E EPS | Applied P/E | Target Price |
|---|---|---|---|
| Bear (30x) | ~₹20 | 30x | ₹600 |
| Base (40x) | ~₹22 | 40x | ₹880 |
| Bull (50x) | ~₹22 | 50x | ₹1,100 |
| Optimistic (55x) | ~₹24 | 55x | ₹1,320 |
Prabhudas Lilladher values the stock at 45x FY27 earnings, arriving at a target of ₹927. The analyst consensus 12-month price target is ₹1,069 with a high estimate of ₹1,328.
Buying Range Assessment
| Zone | Price Range | Verdict |
|---|---|---|
| 🟢 Strong Buy | ₹650 – ₹750 | Excellent margin of safety |
| 🟡 Buy | ₹750 – ₹900 | Reasonable entry for long-term |
| 🟠 Accumulate | ₹900 – ₹1,050 | Fair value; current zone (~₹990) |
| 🔴 Avoid / Wait | > ₹1,100 | Priced for perfection |
At the current price of ~₹990, the stock trades near the upper end of fair value on FY27 estimates. It’s not cheap, but not overvalued if management executes on doubling revenues by FY27.
Future Growth & Earnings Potential
Structural Tailwinds:
- Avalon provides integrated EMS across PCB assemblies, cable/wire harness, sheet metal, aerospace fabrication, magnetics, and system integration — a rare full-stack EMS player in India
- The company entered the semiconductor equipment manufacturing space, partnering with a leading global semiconductor equipment company, expected to be a significant growth driver
- The order book jumped 25.4% to ₹1,863 Cr as of September 2025; H1 FY26 revenue surged 48.7% and net profit soared 158%
- Management targets doubling FY27 revenue again by FY30, driven by new customers in mobility, industrial, and aerospace verticals
Key Risks:
- EBITDA margins declined slightly to 10.1% in Q2 FY26 from 11% a year ago — margin expansion is needed to justify the valuation
- High P/E (~69–90x) leaves little room for earnings misses
- US revenue concentration (~61%) creates tariff/FX risk, though Avalon shares surged 20% on news of an India-US trade deal reducing export tariffs from 50% to 18%
- Working capital intensity and high capex limit near-term FCF generation
Summary Verdict
| Metric | Value |
|---|---|
| Current Price | ~₹990 |
| DCF Intrinsic Value (conservative FCF) | ₹345–380 |
| Earnings-Based Fair Value (FY27, 40–45x) | ₹880–1,000 |
| Analyst Consensus Target | ₹1,069 |
| Ideal Buy Zone | ₹650–₹850 |
| Rating | ACCUMULATE at current levels; BUY on dips below ₹850 |
Avalon is a genuinely strong India EMS growth story — backed by government PLI tailwinds, a dual-shore model, and entry into high-value segments like semiconductors and defence. But at ~₹990, most of the near-term upside is priced in. Patient investors who can hold 3–5 years may still see significant wealth creation if management delivers on its FY27 and FY30 targets.
This is not financial advice. Please consult a SEBI-registered advisor before making investment decisions.